Coulthard Paul, Kushnerev Evgeny, Yates Julian M, Walsh Tanya, Patel Neil, Bailey Edmund, Renton Tara F
Department of Oral and Maxillofacial Surgery, School of Dentistry, The University of Manchester, Coupland III Building, Oxford Road, Manchester, UK, M13 9PL.
Cochrane Database Syst Rev. 2014 Apr 16;2014(4):CD005293. doi: 10.1002/14651858.CD005293.pub2.
Iatrogenic injury of the inferior alveolar or lingual nerve or both is a known complication of oral and maxillofacial surgery procedures. Injury to these two branches of the mandibular division of the trigeminal nerve may result in altered sensation associated with the ipsilateral lower lip or tongue or both and may include anaesthesia, paraesthesia, dysaesthesia, hyperalgesia, allodynia, hypoaesthesia and hyperaesthesia. Injury to the lingual nerve may also affect taste perception on the affected side of the tongue. The vast majority (approximately 90%) of these injuries are temporary in nature and resolve within eight weeks. However, if the injury persists beyond six months it is deemed to be permanent. Surgical, medical and psychological techniques have been used as a treatment for such injuries, though at present there is no consensus on the preferred intervention, or the timing of the intervention.
To evaluate the effects of different interventions and timings of interventions to treat iatrogenic injury of the inferior alveolar or lingual nerves.
We searched the following electronic databases: the Cochrane Oral Health Group's Trial Register (to 9 October 2013), the Cochrane Central Register of Controlled Trials (CENTRAL) (The Cochrane Library 2013, Issue 9), MEDLINE via OVID (1946 to 9 October 2013) and EMBASE via OVID (1980 to 9 October 2013). No language restrictions were placed on the language or date of publication when searching the electronic databases.
Randomised controlled trials (RCTs) involving interventions to treat patients with neurosensory defect of the inferior alveolar or lingual nerve or both as a sequela of iatrogenic injury.
We used the standard methodological procedures expected by The Cochrane Collaboration. We performed data extraction and assessment of the risk of bias independently and in duplicate. We contacted authors to clarify the inclusion criteria of the studies.
Two studies assessed as at high risk of bias, reporting data from 26 analysed participants were included in this review. The age range of participants was from 17 to 55 years. Both trials investigated the effectiveness of low-level laser treatment compared to placebo laser therapy on inferior alveolar sensory deficit as a result of iatrogenic injury.Patient-reported altered sensation was partially reported in one study and fully reported in another. Following treatment with laser therapy, there was some evidence of an improvement in the subjective assessment of neurosensory deficit in the lip and chin areas compared to placebo, though the estimates were imprecise: a difference in mean change in neurosensory deficit of the chin of 8.40 cm (95% confidence interval (CI) 3.67 to 13.13) and a difference in mean change in neurosensory deficit of the lip of 21.79 cm (95% CI 5.29 to 38.29). The overall quality of the evidence for this outcome was very low; the outcome data were fully reported in one small study of 13 patients, with differential drop-out in the control group, and patients suffered only partial loss of sensation. No studies reported on the effects of the intervention on the remaining primary outcomes of pain, difficulty eating or speaking or taste. No studies reported on quality of life or adverse events.The overall quality of the evidence was very low as a result of limitations in the conduct and reporting of the studies, indirectness of the evidence and the imprecision of the results.
AUTHORS' CONCLUSIONS: There is clearly a need for randomised controlled clinical trials to investigate the effectiveness of surgical, medical and psychological interventions for iatrogenic inferior alveolar and lingual nerve injuries. Primary outcomes of this research should include: patient-focused morbidity measures including altered sensation and pain, pain, quantitative sensory testing and the effects of delayed treatment.
医源性下牙槽神经或舌神经或二者损伤是口腔颌面外科手术已知的并发症。三叉神经下颌支的这两个分支受损可能导致同侧下唇或舌或二者感觉改变,可能包括麻醉、感觉异常、感觉障碍、痛觉过敏、感觉异常性疼痛、感觉减退和感觉过敏。舌神经损伤还可能影响患侧舌的味觉。这些损伤绝大多数(约90%)为暂时性,8周内可恢复。然而,如果损伤持续超过6个月,则被视为永久性损伤。手术、药物和心理技术已被用于治疗此类损伤,但目前对于首选干预措施或干预时机尚无共识。
评估不同干预措施及干预时机对医源性下牙槽神经或舌神经损伤的治疗效果。
我们检索了以下电子数据库:Cochrane口腔健康组试验注册库(截至2013年10月9日)、Cochrane对照试验中心注册库(CENTRAL)(《Cochrane图书馆》2013年第9期)、通过OVID检索的MEDLINE(1946年至2013年10月9日)以及通过OVID检索的EMBASE(1980年至2013年10月9日)。检索电子数据库时,对语言和出版日期均未设限制。
随机对照试验(RCT),涉及对医源性损伤所致下牙槽神经或舌神经或二者神经感觉缺陷患者进行干预治疗。
我们采用了Cochrane协作网期望的标准方法程序。我们独立且重复地进行数据提取和偏倚风险评估。我们联系作者以明确研究的纳入标准。
两项被评估为高偏倚风险的研究纳入了本综述,报告了26名分析参与者的数据。参与者年龄范围为17至55岁。两项试验均研究了低强度激光治疗与安慰剂激光治疗相比对医源性损伤所致下牙槽感觉缺陷的有效性。一项研究部分报告了患者报告的感觉改变,另一项则完整报告了该情况。激光治疗后,与安慰剂相比,有一些证据表明唇部和颏部神经感觉缺陷的主观评估有所改善,尽管估计值不精确:颏部神经感觉缺陷平均变化差异为8.40 cm(95%置信区间(CI)3.67至13.13),唇部神经感觉缺陷平均变化差异为21.79 cm(95%CI 5.29至38.29)。该结果的证据总体质量非常低;该结果数据在一项13名患者的小型研究中完整报告,对照组有差异失访,且患者仅存在部分感觉丧失。没有研究报告干预对疼痛、进食或说话困难或味觉等其余主要结局的影响。没有研究报告生活质量或不良事件。由于研究实施和报告方面的局限性、证据的间接性以及结果的不精确性,证据总体质量非常低。
显然需要进行随机对照临床试验来研究手术、药物和心理干预对医源性下牙槽神经和舌神经损伤的有效性。该研究的主要结局应包括:以患者为中心的发病率指标,包括感觉改变和疼痛、定量感觉测试以及延迟治疗的影响。